SCHEMBL18948425

SCHEMBL18948425

CCCCCCCC(CC)c1ccc(Cl)c(Cl)c1

nearest known ligand 0.51

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
NR1I2 O75469 1/20 0.51
SLC6A3 Q01959 10/20 0.44
SLC6A4 P31645 10/20 0.44
SLC6A2 P23975 9/20 0.43
SIGMAR1 Q99720 1/20 0.37
KCNH2 Q12809 3/20 0.37
CYP3A4 P08684 3/20 0.36
CYP2D6 P10635 3/20 0.36
SLC2A1 P11166 1/20 0.36
ABL1 P00519 1/20 0.36
ALDH1A1 P00352 1/20 0.36
LMNA P02545 1/20 0.36
HTT P42858 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29294802 0.93 SLC6A3 (0.48) NR1I2SLC6A3SLC6A4SLC6A2SIGMAR1
SCHEMBL20615433 0.92 SLC6A3 (0.47) NR1I2SLC6A3SLC6A4SLC6A2SIGMAR1
SCHEMBL8277863 0.83 SLC6A3 (0.48) SLC6A3SLC6A4SLC6A2SIGMAR1KCNH2
SCHEMBL2632704 0.82 AHR (0.44) SLC6A3SLC6A4SLC6A2KCNH2CYP3A4
SCHEMBL11486549 0.81 SLC6A4 (0.45) SLC6A3SLC6A4SLC6A2KCNH2CYP3A4
SCHEMBL11484268 0.81 SLC6A3 (0.45) SLC6A3SLC6A4SLC6A2SIGMAR1KCNH2
SCHEMBL11484183 0.81 SLC6A4 (0.45) SLC6A3SLC6A4SLC6A2KCNH2CYP3A4
SCHEMBL11484616 0.81 SLC6A3 (0.45) SLC6A3SLC6A4SLC6A2SIGMAR1KCNH2
SCHEMBL19987475 0.81 NR1I2 (0.59) NR1I2SLC6A3SLC6A4SLC6A2KCNH2
SCHEMBL11493043 0.80 SLC6A3 (0.44) SLC6A3SLC6A4SLC6A2SIGMAR1KCNH2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9676780-B2 Piperazine-substituted [1,2,4]triazolo[1,5-C]quinazolin-5-amine compounds with A2A antagonist properties MERCK SHARP & DOHME CORP. (US) 2017-06-13 US disclosed